This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Herzog, W. R. Articles by Serebruany, V. L. Search for Related Content PubMed PubMed Citation Articles by Herzog, W. R. Articles by Serebruany, V. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Attack Hazardous Substances DB MAGNESIUM COMPOUNDS MAGNESIUM, ELEMENTAL

(Circulation. 1995;92:2622-2626.)
© 1995 American Heart Association, Inc.

Articles

Timing of Magnesium Therapy Affects Experimental Infarct Size

William R. Herzog, MD; Matthew L. Schlossberg, BA; Karen S. MacMurdy, MD; Lisa R. Edenbaum, BA; Matthew J. Gerber, BA; Robert A. Vogel, MD; Victor L. Serebruany, MD

From the University of Maryland Medical Center, Department of Medicine, Division of Cardiology, Baltimore.

Correspondence to William R. Herzog, MD, University of Maryland Medical Center, Department of Medicine, Division of Cardiology N3W77, 22 S Greene St, Baltimore, MD 21201.

Background Controversy exists regarding the use of magnesium in the treatment of acute myocardial infarction (AMI) because of apparent conflicting results from clinical trials. One hypothesis to explain the various clinical observations proposes that the timing of magnesium administration significantly influences its therapeutic effect; ie, supraphysiological levels of Mg²⁺ must be present at the time of reperfusion for magnesium to produce clinical benefit.

Methods and Results These experiments evaluated the effect of varying the timing of magnesium administration during AMI. Female Yorkshire swine (34 to 42 kg) underwent thoracotomy and 50 minutes of left anterior descending coronary artery (LAD) occlusion, followed by 3 hours of reperfusion. In the first group, MgSO₄ (250 mg of magnesium diluted in 60 cm³ saline) was infused into the LAD over 12 minutes, beginning immediately with the onset of reperfusion (n=6, Mg-early group). In the second group, MgSO₄ was given after 1 hour of reperfusion (n=6, Mg-late group). Six pigs received saline instead of magnesium and served as the control group. Lethal arrhythmias were significantly reduced in the Mg-early group. Infarct size was determined by vital staining. Infarct size was 0.16±0.05 g/kg body wt (Mg-early), 0.35±0.08 g/kg (Mg-late), and 0.42±0.04 g/kg for the control group. Compared with the control group, significant (P=.029) reduction in infarct size occurred in the Mg-early group but not in the Mg-late group.

Conclusions We conclude that intracoronary MgSO₄ delivered during reperfusion can significantly diminish infarct size in swine, but the timing of administration is critical.

Key Words: myocardial infarction • magnesium • reperfusion

This article has been cited by other articles:

				M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies Cardiovasc Res, June 1, 2007; 74(3): 343 - 355. [Abstract] [Full Text] [PDF]

				T. Matsusaka, N. Hasebe, Y.-T. Jin, J. Kawabe, and K. Kikuchi Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits Cardiovasc Res, June 1, 2002; 54(3): 568 - 575. [Abstract] [Full Text] [PDF]

				K. Woods Commentary: Biostatistics, biological mechanisms and Bayes: lessons from the magnesium trials Int. J. Epidemiol., February 1, 2002; 31(1): 105 - 106. [Full Text] [PDF]

				H. B. Ravn, U. Moeldrup, C. I. O. Brookes, L. B. Ilkjaer, P. White, M. Chew, L. Jensen, S. Johnsen, L. Birk-Soerensen, and V. E. Hjortdal Intravenous Magnesium Reduces Infarct Size After Ischemia/Reperfusion Injury Combined with a Thrombogenic Lesion in the Left Anterior Descending Artery Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 569 - 574. [Abstract] [Full Text] [PDF]

				H. B. Ravn, S. D. Kristensen, V. E. Hjortdal, K. Thygesen, and S. E.ær Husted Early Administration of Intravenous Magnesium Inhibits Arterial Thrombus Formation Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3620 - 3625. [Abstract] [Full Text]

				C. H. Hennekens, C. M. Albert, S. L. Godfried, J. M. Gaziano, and J. E. Buring Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials N. Engl. J. Med., November 28, 1996; 335(22): 1660 - 1668. [Full Text] [PDF]

				E. M. Antman Magnesium in Acute MI : Timing Is Critical Circulation, November 1, 1995; 92(9): 2367 - 2372. [Full Text]